CCEPH Epidemiologist Presented at ESPID Meeting in Slovenia (May 2019)
CCEPH Epidemiologist Edward Belongia, MD, gave a plenary presentation on "Influenza H3N2 Vaccine Effectiveness in Children" at the annual European Society for Paediatric Infectious Diseases Conference in Ljubljana, Slovenia from May 8 - 10, 2019.
CCEPH Scientist Awarded Seubert Endowment for Cardiology Research (May 2019)
Jeffrey VanWormer, Ph.D., Research Scientist in the Center for Clinical Epidemiology and Population Health (CCEPH) at Marshfield Clinic Research Institute, was recently selected for the Celine Seubert Distinguished Physician/Scientist Endowment in Cardiology research.
CCEPH Researchers and Staff Attend This Year's HCSRN Conference (April 2019)
Center for Clinical Epidemiology and Population Health (CCEPH) researchers and staff attended this year's 25th annual HCSRN Conference in Portland, Oregon. This year's theme was "Celebrating Health Research".
CCEPH Director Presented on U.S. Vaccine Policy Development with Focus on Shingles Vaccine at Annual ACVR Conference (April 2019)
Center for Clinical Epidemiology and Population Health (CCEPH) Director Edward Belongia, MD, recently gave a plenary presentation at the Annual Conference on Vaccinology Research (ACVR), held in Baltimore, Maryland from April 3 - 5, 2019. Dr. Belongia served as Chair of the CDC ACIP Herpes zoster workgroup from 2014 - 2018. During that time, he led the workgroup evaluation of a new highly effective vaccine to prevent shingles and he contributed to the decision to make a preferential recommendation for that vaccine. His ACVR presentation discussed the ACIP approach to evaluating new vaccines and how the decision was made to make a preferential recommendation.
CCEPH Epidemiologist Presents Flu Vaccine Safety Study at CDC ACIP Meeting (February 2019)
Center for Clinical Epidemiology and Population Health (CCEPH) Epidemiologist James Donahue, DVM, PhD, MPH, recently presented a Vaccine Safety Datalink study of flu vaccine and miscarriage at the ACIP meeting in Atlanta, Georgia. The study provided reassuring news with no evidence of vaccine-related risk. The ACIP presentation was reported by STAT News and CNN.
MCRI to Participate in Long-Term Cancer Research (January 2019)
The Marshfield Clinic Research Institute (MCRI) participates with two other Midwestern Institutes in a prospective cancer cohort study. The research will investigate factors that influence the risk of developing or dying from different types of cancer.